SCHEMBL5360178

SCHEMBL5360178

N#Cc1ccc(S(=O)(=O)N2CCCN(c3c(Cl)cncc3Cl)CC2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.57
MAPT P10636 1/20 0.57
NPSR1 Q6W5P4 1/20 0.57
L3MBTL1 Q9Y468 3/20 0.56
GAA P10253 1/20 0.56
HSD11B1 P28845 1/20 0.47
PKM P14618 2/20 0.46
PKLR P30613 1/20 0.46
GBA1 P04062 1/20 0.46
NAMPT P43490 1/20 0.46
ALDH1A1 P00352 3/20 0.44
HPGD P15428 2/20 0.44
MAPK1 P28482 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
KDM4E B2RXH2 2/20 0.44
TDP1 Q9NUW8 1/20 0.44
CCR6 P51684 2/20 0.44
HTT P42858 2/20 0.44
MEN1 O00255 1/20 0.44
CYP2C9 P11712 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5323167 0.84 PKM (0.64) KMT2ANPSR1L3MBTL1GAAHSD11B1
SCHEMBL5326546 0.84 MAPT (0.57) KMT2AMAPTL3MBTL1GAAHSD11B1
SCHEMBL16707660 0.84 MEN1 (0.55) KMT2AL3MBTL1GAAHSD11B1PKM
SCHEMBL5352439 0.82 MCOLN3 (0.50) KMT2AL3MBTL1HSD11B1PKMNAMPT
SCHEMBL5327466 0.81 PKM (0.59) KMT2AMAPTL3MBTL1GAAHSD11B1
SCHEMBL5357244 0.81 KDM4E (0.66) KMT2AL3MBTL1HSD11B1PKMGBA1
SCHEMBL13271173 0.80 USP2 (0.62) KMT2AMAPTNPSR1L3MBTL1GAA
SCHEMBL5351313 0.80 ALDH1A1 (0.61) KMT2AMAPTL3MBTL1GBA1NAMPT
SCHEMBL5351297 0.79 KDM4E (0.59) MAPTL3MBTL1GAAPKMGBA1
SCHEMBL5323174 0.78 MCOLN3 (0.60) KMT2AHSD11B1PKMPKLRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007122411-A1 DIAZEPAN-1-YL-SULFONYL DERIVATIVES FOR THE TREATMENT OF METABOLIC SYNDROME ASTRAZENECA AB (SE) 2007-11-01 WO claimed
WO-2007122411-A1 DIAZEPAN-1-YL-SULFONYL DERIVATIVES FOR THE TREATMENT OF METABOLIC SYNDROME ASTRAZENECA AB (SE) 2007-11-01 WO disclosed